Clinical Trial Update: A Study of sEphB4-HSA in Kaposi Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sEphB4-HSA for Kaposi sarcoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• sEphB4-HSA

Snippet

Sponsor: Vasgene Therapeutics, Inc | Conditions: Kaposi Sarcoma | Phase 2 | Status: RECRUITING